|Bid||398.00 x 2000|
|Ask||404.75 x 10000|
|Day's Range||399.00 - 399.00|
|52 Week Range||399.00 - 399.00|
|PE Ratio (TTM)||-125.35|
|Dividend & Yield||12.00 (3.05%)|
|1y Target Est||N/A|
WALTHAM, Mass., Dec. 16, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred ...
WALTHAM, Mass., Nov. 14, 2016 /PRNewswire/ -- Alere Inc. (ALR), a global leader in rapid diagnostic tests, today announced that it has posted a fact sheet on its website providing additional information regarding its subsidiary Arriva Medical, LLC's relationship with the Centers for Medicare & Medicaid Services (CMS) and its enrollment in the National Mail Order Competition Bid Program ("Program") for Diabetes Testing Supplies (DTS). Arriva is fully accredited by the Accreditation Commission for Health Care (ACHC) and recognized as a leader in compliance. Arriva is the largest Contract Supplier under the Medicare National Mail Order Competitive Bid Program, having been a trusted supplier to CMS for more than seven years.